Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling

Cell Death and Differentiation

Volumn 22, Issue 2, 2015, Pages 258-273

  Yabu, T ^a   Shiba, H ^a   Shibasaki, Y ^a   Nakanishi, T ^a   Imamura, S ^b   Touhata, K ^b   Yamashita, M ^b  

^a NIHON UNIVERSITY   (Japan)

^b FISHERIES RESEARCH AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; CERAMIDE; FAS ANTIBODY; GLUTAMIC ACID; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE 1; SPHINGOMYELIN PHOSPHODIESTERASE 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL STRESS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENVIRONMENTAL STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GOLGI COMPLEX; HEAT SHOCK; HUMAN; HUMAN CELL; IN VITRO STUDY; JURKAT CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING; ZEBRA FISH; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; METABOLISM; PHOSPHORYLATION;

DANIO RERIO; VERTEBRATA;

ANIMALS; APOPTOSIS; CELL LINE; CERAMIDES; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; SPHINGOMYELIN PHOSPHODIESTERASE; ZEBRAFISH;

EID: 84922749204     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.128     Document Type: Article

References (63)

1. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S et al. Requirement for ceramideinitiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-79.
2. Chang Y, Abe A, Shayman JA. Ceramide formation during heat shock: a potential mediator of alpha B-crystallin transcription. Proc Natl Acad Sci USA 1995; 92: 12275-12279.
3. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9: 139-150.
4. Jaffrézou JP, Levade T, Betta?ëb A, Andrieu N, Bezombes C, Maestre N et al. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 1996; 15: 2417-2424.
5. Jana A, Pahan K. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem 2004; 279: 51451-51459.
6. Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 2004; 164: 123-131.
7. Yang Z, Costanzo M, Golde DW, Kolesnick RN. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. J Biol Chem 1993; 268: 20520-20523.
8. Machleidt T, Wiegmann K, Henkel T, Schü tze S, Baeuerle P, Krönke M. Sphingomyelinase activates proteolytic I kappa B-alpha degradation in a cell-free system. J Biol Chem 1994; 269: 13760-13765.
9. Dressler KA, Mathias S, Kolesnick RN. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 1992; 255: 1715-1718.
10. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994; 78: 1005-1015.
11. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S et al. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 1995; 92: 8443-8447.
12. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996; 86: 937-947.
13. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA 1998; 95: 3638-3643.
14. Tomiuk S, Zumbansen M, Stoffel W. Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J Biol Chem 2000; 275: 5710-5717.
15. Tonnetti L, Veri MC, Bonvini E, D'Adamio L. A role for neutral sphingomyelinasemediated ceramide production in T cell receptor-induced apoptosis and mitogenactivated protein kinase-mediated signal transduction. J Exp Med 1999; 189: 1581-1589.
16. Yabu T, Imamura S, Yamashita M, Okazaki T. Identification of Mg2\+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis. J Biol Chem 2008; 283: 29971-29982.
17. Zumbansen M, Stoffel W. Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease. Mol Cell Biol 2002; 22: 3633-3638.
18. Dé rijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-1037.
19. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-160.
20. Sánchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994; 372: 794-798.
21. Sluss HK, Barrett T, Derijard B, Davis RJ. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994; 14: 8376-8384.
22. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR et al. Activation of stressactivated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 1994; 372: 798-800.
23. Dé rijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995; 267: 682-685.
24. Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 1995; 268: 286-290.
25. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Dé rijard B et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996; 15: 2760-2770.
26. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996; 271: 24313-24316.
27. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E et al. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 1997; 94: 3302-3307.
28. Watanabe M, Kitano T, Kondo T, Yabu T, Taguchi Y, Tashima M et al. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis. Cancer Res 2004; 64: 1000-1007.
29. Bogoyevitch MA, Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev 2006; 70: 1061-1095.
30. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681-13686.
31. Adachi M, Fukuda M, Nishida E. Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J 1999; 18: 5347-5358.
32. Wilsbacher JL, Juang YC, Khokhlatchev AV, Gallagher E, Binns D, Goldsmith EJ et al. Characterization of mitogen-activated protein kinase (MAPK) dimers. Biochemistry 2006; 45: 13175-13182.
33. Mizutani Y, Tamiya-Koizumi K, Nakamura N, Kobayashi M, Hirabayashi Y, Yoshida S. Nuclear localization of neutral sphingomyelinase 1: biochemical and immunocytochemical analysis. J Cell Sci 2001; 114: 3727-3736.
34. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitor: an update. Biochem J 2003; 371: 199-204.
35. Clarke CJ, Cloessner EA, Roddy PL, Hannun YA. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-a in MCF-7 cells. Biochem J 2011; 435: 381-390.
36. Sawai H, Domae N, Nagan N, Hannun YA. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J Biol Chem 1999; 274: 38131-38139.
37. Tepper AD, Ruurs P, Borst J, van Blitterswijk WJ. Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis. Biochem Biophys Res Commun 2001; 280: 634-639.
38. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319: 244-247.
39. Ö ö rni K, Hakala JK, Annila A, Ala-Korpela M, Kovanen PT. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. J Biol Chem 1998; 273: 29127-29134.
40. Veiga MP, Arrondo JL, Goni FM, Alonso A. Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys J 1999; 76: 342-350.
41. Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, Schwandner R et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 1999; 18: 5252-5263.
42. Huwiler A, Johansen B, Skarstad A, Pfeilschifter J. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB J 2001; 15: 7-9.
43. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003; 426: 803-809.
44. Dbaibo GS, Perry DK, Gamard CJ, Platt R, Poirier GG, Obeid LM et al. Cytokine response modifier A (CrmA) Inhibits ceramide formation in response to tumor necrosis factor (TNF)-a: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 1997; 185: 481-490.
45. Wei Y, Wang D, Topczewski F, Pagliassotti M J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 2006; 291: 275-281.
46. Shimabukuro M, Zhou Y T, Levi M, Unger R H. Fatty acid-induced b cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95: 2498-2502.
47. Hanada K, Hara T, Fukasawa M, Yamaji A, Umeda M, Nishijima M. Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin: genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J Biol Chem 1998; 273: 33787-33794.
48. Listenberger L L, Ory D S, Schaffer J E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001; 276: 14890-14895.
49. Sparagna G C, Hickson-Bick D L, Buja L M, McMillin J B. A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol 2000; 279: 2124-2132.
50. Strasser A, Jost P J, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30: 180-192.
51. Li H, Zhu H, Xu C J, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
52. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-490.
53. Yang X, Khosravi-Far R, Chang H Y, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067-1076.
54. Khelifi A F, D'Alcontres M S, Salomoni P. Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ 2005; 12: 724-733.
55. Lei K, Davis R J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 2003; 100: 2432-2432.
56. Putcha G V, Moulder K L, Golden J P, Bouillet P, Adams J A, Strasser A et al. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 2001; 29: 615-628.
57. Putcha G V, Le S, Frank S, Besirli C G, Clark K, Chu B et al. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 2003; 38: 899-914.
58. Watts JD, Gu M, Polverino AJ, Patterson SD, Aebersold R. Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc Natl Acad Sci USA 1997; 94: 7292-7296.
59. Caricchio R, D'Adamio L, Cohen PL. Fas, ceramide and serum withdrawal induce apoptosis via a common pathway in a type II Jurkat cell line. Cell Death Differ 2002; 9: 574-580.
60. Yabu T, Kishi S, Okazaki T, Yamashita M. Characterization of zebrafish caspase-3 and induction of apoptosis through ceramide generation in fish fathead minnow tailbud cells and zebrafish embryo. Biochem J 2001; 360: 39-47.
61. Yabu T, Shimuzu A, Yamashita M. A novel mitochondrial sphingomyelinase in zebrafish cells. J Biol Chem. 2009; 284: 20349-20363.
62. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
63. Okazaki T, Bell RM, Hannun YA. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 1989; 264: 19076-19080.